Anthropic's Path Toward a Reported $2 Trillion IPO
Anthropic's shareholders are targeting an initial public offering in October at a valuation around $2 trillion, according to a Financial Times report cited by Expansion. If achieved, the listing would roughly double the company's $965 billion valuation from May and surpass the $1.77 trillion mark reached by SpaceX in a June public share sale.
The AI developer has leaned heavily into the enterprise market, and that strategy is showing up in its growth numbers. Anthropic said in May that annualized revenue had passed $47 billion, while investors expect the figure to reach $100 billion to $120 billion by late 2026 — a more than tenfold increase in annualized revenue over the period.
An October debut would allow Anthropic to reach public markets before rival OpenAI, making it the first major generative AI company to list as a direct AI play. Still, the company faces headwinds: cheaper Chinese models are intensifying competition, regulatory pressure is building, and a June restriction on its most advanced AI model contributed to slower revenue growth.
The company, founded in 2021, submitted confidential paperwork to the US Securities and Exchange Commission in June and has raised nearly $100 billion from investors in 2026. However, the amount it expects to raise in the IPO has not been disclosed, and management has yet to set a definitive internal target for the valuation, the report said.
Valuation Math and the Race With OpenAI
The numbers behind the reported target leave little room for a conventional valuation debate. If Anthropic hits the high end of the revenue expectation, a $2 trillion market value implies roughly 17 times forward annualized revenue; at the lower end, the multiple rises to around 20 times. That is an aggressive growth bet, not a pricing anchored to current profitability.
Anthropic's valuation math
At $2 trillion, the valuation would be more than twice the $965 billion investors assigned in May. The jump depends on enterprise revenue continuing to scale at an unusual pace. Because the company has not fixed an internal target, the floated $2 trillion figure is best read as a shareholder ambition rather than a commitment.
The OpenAI race and the public-market bar
Going public in October would make Anthropic the first major generative AI company to test public investors before OpenAI. The comparison with SpaceX is imperfect because SpaceX pairs its AI work with aerospace operations; Anthropic would be evaluated almost entirely on its AI business. That makes revenue growth, model access and enterprise contracts the core valuation drivers.
Where the risks could cut the other way
Cheaper Chinese models create direct pricing pressure on enterprise AI services, while the June restriction on Anthropic's most advanced model shows that regulatory or administrative action can quickly affect revenue. If those pressures persist into the final IPO pricing, the gap between a $2 trillion ambition and the achievable market value could widen.
What the October Timeline Means for Investors and AI Buyers
The reported IPO plan gives different audiences concrete things to address between now and October.
- For institutional investors evaluating the listing: Focus on the enterprise revenue mix and model-access restrictions in the eventual S-1, not the $2 trillion headline. The reported math implies a 17–20x forward revenue multiple based on the $100–120 billion annualized revenue expectation.
- For companies using Claude or Anthropic's models: Build contingency access for critical workloads. The June restriction on its most advanced model has already slowed revenue growth, showing that even leading models can face administrative or regulatory interruption.
- For competitors and private AI investors: Treat the October window as a public valuation benchmark. If Anthropic prices well below $2 trillion, it may reset how private generative AI rounds are valued; if it prices near the target, it strengthens the case for AI-first public listings.
Risk & Opportunity Assessment
| Commercial Risk | High | A $2 trillion valuation requires revenue to jump from $47 billion in May to $100–120 billion by late 2026; slower growth caused by cheaper Chinese models or model restrictions would make that target hard to defend. |
| Competitive Risk | High | Cheaper Chinese AI models and OpenAI's competing generative AI business are direct pressures, and an IPO ahead of OpenAI raises the public comparison. |
| Regulatory Risk | High | Tensions with the US administration and a June restriction on its most advanced AI have already affected revenue, and the SEC filing process remains confidential. |
| Reputation Risk | Medium | The floated $2 trillion valuation is well above the $965 billion May mark and not yet fixed internally; missing that public expectation could create negative IPO coverage. |
| Technology Disruption | High | The company's own product is disruptive, but it is exposed to faster-moving, cheaper alternatives from Chinese AI developers. |
| Commercial Opportunity | Transformational | A successful IPO at this scale would mark the first major pure-play generative AI listing and could re-rate the entire AI sector. |
Comments 0